These drugs are prescribed for bipolar disorder in teens and preschoolers, and for affective psychoses in children aged 7 to 12. Little clinical research with children on the effectiveness and safety of the drugs in these groups has been carried out, however. The panel asked for label revisions regarding pediatric use and adverse events when these drugs are approved for new pediatric indications.
To read more on the use of antipsychotics in children and adolescents, see Psychiatric News at http://pn.psychiatryonline.org/content/46/12/18.2.
(Image: Mikael Damkier/Shutterstock.com)